Moderna says COVID shot for younger kids showed strong results

Syringes loaded with doses of the Moderna coronavirus vaccine are ready to be used during a clinic at CASA de Maryland's Wheaton Welcome Center on May 21, 2021, in Wheaton, Maryland. (Chip Somodevilla/Getty Images/TNS)

Moderna Inc. said that its COVID-19 vaccine showed a strong immune response in younger children in a late-stage clinical trial, paving the way for submission to regulators for clearance in those ages 6 through 11.